Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

28.21
-0.6050-2.10%
Volume:5.97M
Turnover:168.83M
Market Cap:6.58B
PE:-45.27
High:29.16
Open:28.30
Low:27.80
Close:28.81
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:0.73
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:20.31
PE(LYR):55.06

Loading ...

Hims & Hers Stock Sinks. Why Earnings Offered Wall Street a Big Surprise. -- Barrons.com

Dow Jones
·
May 12

BUZZ-Hims & Hers falls after Q1 loss, revenue miss

Reuters
·
May 12

Earnings Flash (HIMS) Hims & Hers Health Posts Q1 Per Share Loss of $0.40, vs. FactSet Est EPS of $0.03

MT Newswires Live
·
May 12

Hims & Hers Q1 Swings to Loss, Revenue Rises; Issues Guidance

MT Newswires Live
·
May 12

Hims & Hers Health swings to Q1 net loss on restructuring charges, GLP-1 strategic pivot

Reuters
·
May 12

Hims & Hers Q1 Subscribers (End Of Period) 2.584M Up 9% From 2.366M YoY

Benzinga Earnings
·
May 12

Hims & Hers Q1 FY26 net loss turns to USD 92.1 million; revenue rises 4% to USD 608.1 million

Reuters
·
May 12

Hims & Hers Health Q1 EPS $(0.40) Misses $0.04 Estimate, Sales $608.104M Miss $616.853M Estimate

Benzinga Earnings
·
May 12

Hims & Hers raises 2026 revenue forecast

Reuters
·
May 12

Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 8% at $31.54

THOMSON REUTERS
·
May 12

BRIEF-Hims & Hers Health Q1 Revenue USD 608 Million Vs. IBES Estimate USD 616.9 Million

Reuters
·
May 12

Hims & Hers Health - Have High Conviction in 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adjusted Ebitda

THOMSON REUTERS
·
May 12

Hims & Hers Health - Outlook Q2 Revenue $680 Million to $700 Million

THOMSON REUTERS
·
May 12

Hims & Hers Health Q1 EPS USD -0.4

THOMSON REUTERS
·
May 12

Press Release: Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

Dow Jones
·
May 12

U.S. Earnings Preview: After Market Close May 11

Dow Jones
·
May 12

Should Hims & Hers Health’s AI and GLP-1 Push Require Action From Hims & Hers Health (HIMS) Investors?

Simply Wall St.
·
May 11

Stock Track | Hims & Hers Health Soars 5.09% in Pre-Market on Potential FDA Leadership Change and Weight-Loss Drug Partnerships

Stock Track
·
May 11

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), BridgeBio Pharma (BBIO) and Globus Medical (GMED)

TIPRANKS
·
May 11

Hims & Hers Health (HIMS) Gets a Buy from Barclays

TIPRANKS
·
May 11